173 related articles for article (PubMed ID: 37816389)
41. Gender-Affirming Hormone Therapy and Bone Health: Do Different Regimens Influence Outcomes in Transgender Adults? A Narrative Review and Call for Future Studies.
Cirrincione LR; Narla RR
J Appl Lab Med; 2021 Jan; 6(1):219-235. PubMed ID: 33432334
[TBL] [Abstract][Full Text] [Related]
42. Hormone therapy and venous thromboembolism among postmenopausal women.
Scarabin PY
Front Horm Res; 2014; 43():21-32. PubMed ID: 24943295
[TBL] [Abstract][Full Text] [Related]
43. Sperm quality in transgender women before or after gender affirming hormone therapy-A prospective cohort study.
Rodriguez-Wallberg KA; Häljestig J; Arver S; Johansson ALV; Lundberg FE
Andrology; 2021 Nov; 9(6):1773-1780. PubMed ID: 33683832
[TBL] [Abstract][Full Text] [Related]
44. Gender-affirming pharmacotherapy and additional health considerations: A contemporary review.
Mercer J; Bandy S; Tang H; Wenger B; Ryan L; Lee G; Lipscomb J
J Am Pharm Assoc (2003); 2023; 63(6):1669-1676.e1. PubMed ID: 37619851
[TBL] [Abstract][Full Text] [Related]
45. Effects of gender affirming hormone therapy on body mass index in transgender individuals: A longitudinal cohort study.
Suppakitjanusant P; Ji Y; Stevenson MO; Chantrapanichkul P; Sineath RC; Goodman M; Alvarez JA; Tangpricha V
J Clin Transl Endocrinol; 2020 Sep; 21():100230. PubMed ID: 32685379
[TBL] [Abstract][Full Text] [Related]
46. Priorities for efficacy trials of gender-affirming hormone therapy with estrogen: collaborative design and results of a community survey.
Grock S; Weinreb J; Williams KC; Weimer A; Fadich S; Patel R; Geft A; Korenman S
Hormones (Athens); 2024 Jun; 23(2):287-295. PubMed ID: 38311658
[TBL] [Abstract][Full Text] [Related]
47. Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy.
Goldstein Z; Khan M; Reisman T; Safer JD
J Blood Med; 2019; 10():209-216. PubMed ID: 31372078
[No Abstract] [Full Text] [Related]
48. Gender affirming hormonal treatment in Danish transgender persons: A nationwide register-based study.
Glintborg D; Rubin KH; Kristensen SB; Lidegaard Ø; T'Sjoen G; Hilden M; Andersen MS
Andrology; 2022 Jul; 10(5):885-893. PubMed ID: 35366390
[TBL] [Abstract][Full Text] [Related]
49. Barriers and Facilitators to Gender-affirming Hormone Therapy in the Veterans Health Administration.
Wolfe HL; Boyer TL; Shipherd JC; Kauth MR; Jasuja GK; Blosnich JR
Ann Behav Med; 2023 Nov; 57(12):1014-1023. PubMed ID: 37436725
[TBL] [Abstract][Full Text] [Related]
50. Transgender Medicine and Risk of Venous Thromboembolism.
Bunderen CCV; Leentjens J; Middeldorp S
Hamostaseologie; 2022 Oct; 42(5):301-307. PubMed ID: 36323277
[TBL] [Abstract][Full Text] [Related]
51. Changes in depression symptom profile with gender-affirming hormone use in transgender persons.
Morssinkhof MWL; Wiepjes CM; van den Heuvel OA; Kreukels BPC; van der Tuuk K; T'Sjoen G; den Heijer M; Broekman BFP
J Affect Disord; 2024 Mar; 348():323-332. PubMed ID: 38154588
[TBL] [Abstract][Full Text] [Related]
52. Hormone therapy and recurrence of venous thromboembolism among postmenopausal women.
Olié V; Plu-Bureau G; Conard J; Horellou MH; Canonico M; Scarabin PY
Menopause; 2011 May; 18(5):488-93. PubMed ID: 21178641
[TBL] [Abstract][Full Text] [Related]
53. Sex hormones, insomnia, and sleep quality: Subjective sleep in the first year of hormone use in transgender persons.
Morssinkhof MWL; Wiepjes CM; Bosman BW; Kinds J; Fisher AD; Greenman Y; Kreukels BPC; T'Sjoen G; van der Werf YD; Heijer MD; Broekman BFP
Sleep Med; 2023 Jul; 107():316-326. PubMed ID: 37271109
[TBL] [Abstract][Full Text] [Related]
54. Long-term effect of gender-affirming hormone treatment on depression and anxiety symptoms in transgender people: A prospective cohort study.
Aldridge Z; Patel S; Guo B; Nixon E; Pierre Bouman W; Witcomb GL; Arcelus J
Andrology; 2021 Nov; 9(6):1808-1816. PubMed ID: 32777129
[TBL] [Abstract][Full Text] [Related]
55. Effectiveness and Safety of Different Estradiol Regimens in Transgender Women (TREAT Study): Protocol for a Randomized Controlled Trial.
Cortez S; Moog D; Lewis C; Williams K; Herrick C; Fields M; Gray T; Guo Z; Nicol G; Baranski T
JMIR Res Protoc; 2023 Dec; 12():e53092. PubMed ID: 38133914
[TBL] [Abstract][Full Text] [Related]
56. Effects of gender-affirming hormone therapy on body fat: a retrospective case‒control study in Chinese transwomen.
Pei Q; Song Y; Huang Z; Yu H; Xu H; Ye X; Gao L; Gong J; Tian X
Lipids Health Dis; 2024 May; 23(1):146. PubMed ID: 38760846
[TBL] [Abstract][Full Text] [Related]
57. Venous Thrombotic Risk in Transgender Women Undergoing Estrogen Therapy: A Systematic Review and Metaanalysis.
Khan J; Schmidt RL; Spittal MJ; Goldstein Z; Smock KJ; Greene DN
Clin Chem; 2019 Jan; 65(1):57-66. PubMed ID: 30602475
[TBL] [Abstract][Full Text] [Related]
58. A Proposed Inventory to Assess Changes in Orgasm Function of Transgender Patients Following Gender Affirming Treatments: Pilot Study.
Zaliznyak M; Lauzon M; Stelmar J; Yuan N; Smith SM; Garcia MM
Sex Med; 2022 Jun; 10(3):100510. PubMed ID: 35472753
[TBL] [Abstract][Full Text] [Related]
59. Prostate cancer in transgender women: what does a urologist need to know?
Bertoncelli Tanaka M; Sahota K; Burn J; Falconer A; Winkler M; Ahmed HU; Rashid TG;
BJU Int; 2022 Jan; 129(1):113-122. PubMed ID: 34157213
[TBL] [Abstract][Full Text] [Related]
60. Characteristics and gender affirming healthcare needs of transgender and non-binary students starting hormone therapy in a student health service in Aotearoa New Zealand.
Carroll R; Sepulveda B; McLeod L; Stephenson C; Carroll RW
J Prim Health Care; 2023 Jun; 15(2):106-111. PubMed ID: 37390028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
